iBET is a private non-profit research institution specialized in biotechnology research and bioprocess development. iBET acts as an interface between academia and industry while also creating and organizing autonomous knowledge. Our expertise includes the development of bioprocesses for complex biopharmaceuticals and advanced therapies, including vaccines, recombinant proteins, and viral vectors for gene and onco- therapy, stem cells for cell therapy applications; development of in-vitro cell models and protocols for pre-clinical research; analytical tools for quality control of biologics; and structural biology for assisted drug design. Within Food and Health, we develop new solutions for the detection of food frauds, food and water-borne pathogens, and work on the discovery of new bioactive food supplements. To address some environmental issues, we also develop new sustainable, energy saving, processes for both food and water industries. iBET’s infrastructure comprises more than 20 R&D laboratories, a GMP certified Analytical Services Unit, a Mass Spectrometry Unit and a Late-Stage R&D and Bioproduction Unit (2000m2). The new iBET Biofarma building added 29 laboratories to its research and analytical platform infrastructure, including one BLS3 Lab. As an R&D institution, iBET has coordinated over 30 international projects and participated as work-package leader in more than 100 EU-funded projects. iBET has also been involved in some of the most prestigious RD&I and technology transfer projects, with remarkable international impact and has several well established collaborations in Networks of Excellence and with international pharmaceutical companies, such as Bayer, Novartis, Merck, Abbvie, Sanofi, Apceth, AstraZeneca, Glaxo-Smith-Kline , Merck & Co., among others. iBET’s success relies heavily on its large staff of over 250 people, of which about 110 have a PhD degree, and who contribute with advanced skills and experience to our areas of expertise.
View Top Employees from iBET - Instituto de Biologia Experimental e TecnológicaWebsite | http://www.ibet.pt |
Revenue | $19 million |
Employees | 241 (141 on RocketReach) |
Founded | 1989 |
Address | PO Box, Oeiras, Lisbon 2781-901, PT |
Phone | +351 21 446 9566 |
Technologies |
JavaScript,
HTML,
PHP
+34 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Proteins, Business Services, Vaccines, Biopharmaceuticals, Bioprocess development, Pre-clinical models, Cell Lines, Pilot Plant, Analytical Services, Nutraceuticals, Cell based assays, Viral vectors, Stem cells |
Web Rank | 3 Million |
Keywords | Biotechnology, Bioprocessing, Biopharmaceuticals, Advanced Therapies, Vaccine Development, Recombinant Proteins |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular iBET - Instituto de Biologia Experimental e Tecnológica employee's phone or email?
The iBET - Instituto de Biologia Experimental e Tecnológica annual revenue was $19 million in 2024.
Armindo Rodrigues is the Head of IT of iBET - Instituto de Biologia Experimental e Tecnológica.
141 people are employed at iBET - Instituto de Biologia Experimental e Tecnológica.
iBET - Instituto de Biologia Experimental e Tecnológica is based in Oeiras, Lisbon.
The NAICS codes for iBET - Instituto de Biologia Experimental e Tecnológica are [541, 54171, 541713, 5417, 54].
The SIC codes for iBET - Instituto de Biologia Experimental e Tecnológica are [87, 873].